Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04736706 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) |
| First Submitted : | January 29, 2021 |
| First Submitted that Met QC Criteria : | January 29, 2021 |
| First Posted : | February 3, 2021 |
| Last Update Submitted that Met QC Criteria : | March 11, 2024 |
| Last Update Posted : | March 12, 2024 |